Philippa Howden-Chapman

Prof. Philippa Howden-Chapman

He Kainga Oranga/Housing and Health Research Programme, Department of Public Health, University of Otago, Wellington, New Zealand
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2018 in Sustainability Science
Verified
Journal Article
Open access
PDF file
MNMåns Nilsson
Måns Nilsson
ECElinor Chisholm
Elinor Chisholm
DGDavid Griggs
David Griggs
PHPhilippa Howden-Chapman
Philippa Howden-Chapman
DMDavid McCollum
David McCollum
MSM. (Mark) Stafford Smith
M. (Mark) Stafford Smith
Pursuing integrated research and decision-making to advance action on the sustainable development goals (SDGs) fundamentally depends on understanding interactions between the SDGs, both negative ones (“trade-offs”) and positive ones (“co-benefits”). This quest, triggered by the 2030 Agenda, has however pointed to a gap in current research and policy analysis regarding how to think systematically about interactions across the SDGs. This paper synthesizes experiences and insights from the application of a new conceptual framework for mapping and assessing SDG interactions using a defined typology and characterization approach. Drawing on results from a major international research study applied to the SDGs on health, energy and the ocean, it analyses how interactions depend on key factors such as geographical context, resource endowments, time horizon and governance. The paper discusses the future potential, barriers and opportunities for applying the approach in scientific research, in policy making and in bridging the two through a global SDG Interactions Knowledge Platform as a key mechanism for assembling, systematizing and aggregating knowledge on interactions.

23 September 2008 in BMJ
Verified
Journal Article
Open access
PDF file
PHPhilippa Howden-Chapman
Philippa Howden-Chapman
NPNevil Pierse
Nevil Pierse
SNSarah Nicholls
Sarah Nicholls
JGJulie Gillespie-Bennett
Julie Gillespie-Bennett
HVHelen Viggers
Helen Viggers
JCJulian Crane
Julian Crane
Objective To assess whether non-polluting, more effective home heating (heat pump, wood pellet burner, flued gas) has a positive effect on the health of children with asthma.Design Randomised controlled trial.Setting Households in five communities in New Zealand.Participants 409 children aged 6-12 years with doctor diagnosed asthma.Interventions Installation of a non-polluting, more effective home heater before winter. The control group received a replacement heater at the end of the trial.Main outcome measures The primary outcome was change in lung function (peak expiratory flow rate and forced expiratory volume in one second, FEV1). Secondary outcomes were child reported respiratory tract symptoms and daily use of preventer and reliever drugs. At the end of winter 2005 (baseline) and winter 2006 (follow-up) parents reported their child’s general health, use of health services, overall respiratory health, and housing conditions. Nitrogen dioxide levels were measured monthly for four months and temperatures in the living room and child’s bedroom were recorded hourly.Results Improvements in lung function were not significant (difference in mean FEV1 130.7 ml, 95% confidence interval −20.3 to 281.7). Compared with children in the control group, however, children in the intervention group had 1.80 fewer days off school (95% confidence interval 0.11 to 3.13), 0.40 fewer visits to a doctor for asthma (0.11 to 0.62), and 0.25 fewer visits to a pharmacist for asthma (0.09 to 0.32). Children in the intervention group also had fewer reports of poor health (adjusted odds ratio 0.48, 95% confidence interval 0.31 to 0.74), less sleep disturbed by wheezing (0.55, 0.35 to 0.85), less dry cough at night (0.52, 0.32 to 0.83), and reduced scores for lower respiratory tract symptoms (0.77, 0.73 to 0.81) than children in the control group. The intervention was associated with a mean temperature rise in the living room of 1.10°C (95% confidence interval 0.54°C to 1.64°C) and in the child’s bedroom of 0.57°C (0.05°C to 1.08°C). Lower levels of nitrogen dioxide were measured in the living rooms of the intervention households than in those of the control households (geometric mean 8.5 μg/m3 v 15.7 μg/m3, P<0.001). A similar effect was found in the children’s bedrooms (7.3 μg/m3 v 10.9 μg/m3, P<0.001).Conclusion Installing non-polluting, more effective heating in the homes of children with asthma did not significantly improve lung function but did significantly reduce symptoms of asthma, days off school, healthcare utilisation, and visits to a pharmacist.Trial registration Clinical Trials NCT00489762.

3 April 2023 in Annual Review of Public Health
Verified
Journal Article
Open access
PHPhilippa Howden-Chapman
Philippa Howden-Chapman
JBJulie Bennett
Julie Bennett
RERichard Edwards
Richard Edwards
DJDavid Jacobs
David Jacobs
KNKim Nathan
Kim Nathan
DODavid Ormandy
David Ormandy
Housing quality is essential for population health and broader well-being. The World Health Organization Housing and health guidelines highlight interventions that protect occupants from cold and hot temperatures, injuries, and other hazards. The COVID-19 pandemic has emphasized the importance of ventilation standards. Housing standards are unevenly developed, implemented, and monitored globally, despite robust research demonstrating that retrofitting existing houses and constructing high-quality new ones can reduce respiratory, cardiovascular, and infectious diseases. Indigenous peoples, ethnic minorities, and people with low incomes face cumulative disadvantages that are exacerbated by poor-quality housing. These can be partially ameliorated by community-based programs to improve housing quality, particularly for children and older people, who are hospitalized more often for housing-related illnesses. There is renewed interest among policy makers and researchers in the health and well-being of people in public and subsidized housing, who are disproportionately disadvantaged by avoidable housing-related diseases and injuries. Improving the overall quality of new and existing housing and neighborhoods has multiple cobenefits, including reducing carbon emissions.

RCRalph Chapman
Ralph Chapman
MKMichael Keall
Michael Keall
PHPhilippa Howden-Chapman
Philippa Howden-Chapman
MGMark Grams
Mark Grams
KWKaren Witten
Karen Witten
AWAlistair Woodward
Alistair Woodward
Active travel (walking and cycling) is beneficial for people’s health and has many co-benefits, such as reducing motor vehicle congestion and pollution in urban areas. There have been few robust evaluations of active travel, and very few studies have valued health and emissions outcomes. The ACTIVE before-and-after quasi-experimental study estimated the net benefits of health and other outcomes from New Zealand’s Model Communities Programme using an empirical analysis comparing two intervention cities with two control cities. The Programme funded investment in cycle paths, other walking and cycling facilities, cycle parking, ‘shared spaces’, media campaigns and events, such as ‘Share the Road’, and cycle-skills training. Using the modified Integrated Transport and Health Impacts Model, the Programme’s net economic benefits were estimated from the changes in use of active travel modes. Annual benefits for health in the intervention cities were estimated at 34.4 disability-adjusted life years (DALYs) and two lives saved due to reductions in cardiac disease, diabetes, cancer, and respiratory disease. Reductions in transport-related carbon emissions were also estimated and valued. Using a discount rate of 3.5%, the estimated benefit/cost ratio was 11:1 and was robust to sensitivity testing. It is concluded that when concerted investment is made in active travel in a city, there is likely to be a measurable, positive return on investment.

1 March 2019 in Atmospheric Pollution Research
Verified
Journal Article
Closed access
JBJulie Bennett
Julie Bennett
PDPerry Davy
Perry Davy
BTBill Trompetter
Bill Trompetter
YWYu Wang
Yu Wang
NPNevil Pierse
Nevil Pierse
PHPhilippa Howden-Chapman
Philippa Howden-Chapman

1 December 1999 in The Lancet
Verified
Journal Article
Closed access
Simon HalesSimon Hales
Simon Hales
PHPhilippa Howden-Chapman
Philippa Howden-Chapman
CSClare Salmond
Clare Salmond
AWAlistair Woodward
Alistair Woodward
JMJohan Mackenbach
Johan Mackenbach